Latest News and Press Releases

Rapid7 announces financial results for the first quarter 2025.

Earnings Release Highlights First quarter GAAP Net Income (Loss) Attributable to Stockholders of $(135) million. First quarter Adjusted EBITDA of $200 million and Adjusted Free Cash Flow of $87...

Key Q1 2025 Highlights Revenue and Adj. Revenue(1): $751MPre-tax Income (Loss): $(56)MAdj. EBITDA Margin(1): 4.9%New Business Signings ACV(2): $109MNet ARR Activity Metric(2) (TTM): $116M FLORHAM...

CARLSBAD, Calif., May 05, 2025 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today reported financial results for the quarter ended March 31,...

CARLSBAD, Calif., April 21, 2025 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing, will release financial results for the quarter ended March 31, 2025, before...

Rapid7 announces that the company will release its first quarter 2025 financial results on Monday, May 12, 2025, after the financial markets close.

SANTA CLARA, Calif., April 08, 2025 (GLOBE NEWSWIRE) -- AMD (NASDAQ: AMD) announced today that it will report fiscal first quarter 2025 financial results on Tuesday, May 6, 2025, after the close of...

Total revenue was €50.4 mm in Q1 2024, while net gaming revenue1 was €53.0 mm in the period, 34% above Q1 2023.Mexico revenue was €23.8 mm in Q1 2024, while net gaming revenue was €26.6 mm in the...

CARLSBAD, Calif., May 13, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today reported financial results for the quarter ended March 31,...

Barinthus Bio Reports First Quarter 2024 Financial Results and Update on Corporate Developments